Stem Cell Assurance Now Trading on Pink Sheets Under Ticker TRXX BOCA RATON, FL, April 24 /PRNewswire-FirstCall/ -- Stem Cell Assurance (The Company) (Other OTC:TRXX.PK ) today announced that the Company has completed its merger with TRXX, Inc. and is now trading on the Pink Sheets under ticker symbol "TRXX." The merger was completed in a 302M restricted stock transaction on 17th April, 2009. Reorganization is now complete, the previous Pink Sheets filings brought up to date and the management of TRXX, Inc. has resigned. Gloria McConnell, the President of Stem Cell Assurance, will assume control of the Company along with the Stem Cell Assurance board of directors. Stem Cell Assurance is the first company to provide adult stem cell collection and banking service to the general adult population and pipeline cosmetic and therapeutic products. http://www.stemcellassurance.com/ Gloria McConnell, President of Stem Cell Assurance and Traxxec Inc, said, "We are very pleased to complete the merger agreement and now have the stock available to pursue our aggressive national expansion plans for clinical centres and the launch of our Cosmetic and Therapeutic products. It has taken a significant amount of work but we have finally arrived with widespread expert and Industry support. We have a strong Company and we will hit the ground running for our core shareholders and our new shareholders with exciting developments, product lines and new collection centres nationally. We have a significant number of clinical and medical support and associations in place and sales agreements to announce over the coming weeks and months." About Stem Cell Assurance Stem Cell Assurance is one of the nation's first companies to provide adult stem cell collection and banking service to the general adult population. The collection process performed by Stem Cell Assurance is medically proven to be the least invasive, painless and the safest form of adult stem cell collection. We are a company of doctors and scientists that specialize in the collection, processing, and long term storage of your own adult stem cells for your own therapeutic use in the future, if the need arises. Stem Cell Assurance combined Management Team and Board of Directors has extensive experience in the healthcare industry. Collectively, we have expert experience in the stem cell science, general medical industry, life science marking, business management, capital raising, clinical trials and strategic partnering. Dr. Richard Ferrans - M.D. - Chairman, Dr. Vikki Hufnagel - M.D. - Medical Director Gloria McConnell - President, Dr. Kurk Wagner - M.D. - Medical Advisory Board, Dr. Leonard Haimes - M.D. - Medical Advisory Board, Dr. Glenn Charles - D.O. - Medical Advisory Board, Richard Proodian - CFO and Vice President of Finance, George Dubec - Vice President of Marketing, Mandy Clark - Vice President of Operations. See http://www.stemcellassurance.com/ for more information DATASOURCE: Traxxec Inc. CONTACT: Investor Relations: George Dubec, Stem Cell Assurance, (561) 914-2886, , http://www.stemcellassurance.com/

Copyright